iPSC-BASED IMMUNOTHERAPY DIFFERENTIATION PLATFORM ENABLES FEEDER-FREE EXPANSION OF NK CELLS TO CLINICAL SCALE

D Terheyden-Keighley, B Hiller, A Gamerschlag… - Cytotherapy, 2024 - Elsevier
Background & Aim Human induced pluripotent stem cells (iPSCs) are emerging as a potent
starting material for allogeneic cell therapies. As a prerequisite, we have established a GMP …

Fit-for-all iPSC-derived cell therapies and their evaluation in humanized mice with NK cell immunity

C Flahou, T Morishima, H Takizawa… - Frontiers in …, 2021 - frontiersin.org
Human induced pluripotent stem cells (iPSCs) can be limitlessly expanded and
differentiated into almost all cell types. Moreover, they are amenable to gene manipulation …

A Scalable, Off-the-Shelf, and Cost-Effective NK Cell Manufacturing Platform for Developing NK Cell-Based Immunotherapy

Y Yan, L Jiang, Z Zhu, Z Zhu, M Wei, Y Liang, L Shu… - Blood, 2023 - Elsevier
Natural killer (NK) cells are innate lymphocytes that play a key role in the control of infection
and malignancy. NK cells are potent killers of target cells and act in an MHC-independent …

Induced pluripotent stem cell (iPSC)–derived lymphocytes for adoptive cell immunotherapy: recent advances and challenges

A Nianias, M Themeli - Current hematologic malignancy reports, 2019 - Springer
Abstract Purpose of Review In the rapidly developing field of adoptive cell immunotherapy,
there is urgent need for discoveries that would improve outcomes, extend the applicability …

[HTML][HTML] Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy

KV Woan, H Kim, R Bjordahl, ZB Davis, S Gaidarova… - Cell Stem Cell, 2021 - cell.com
Select subsets of immune effector cells have the greatest propensity to mediate antitumor
responses. However, procuring these subsets is challenging, and cell-based …

[HTML][HTML] Immune Cell Generation from Human-Induced Pluripotent Stem Cells: Current Status and Challenges

YY Xiong, YW Zheng - 2023 - intechopen.com
The immune system plays a crucial role in recognizing and eliminating foreign antigens,
working in conjunction with other bodily systems to maintain the stability and physiological …

[HTML][HTML] Development of innate immune cells from human pluripotent stem cells

D Bernareggi, S Pouyanfard, DS Kaufman - Experimental hematology, 2019 - Elsevier
Mouse and human pluripotent stem cells have been widely used to study the development
of the hematopoietic and immune systems. Although not all cells can be derived with the …

Engineering induced pluripotent stem cells for cancer immunotherapy

Y Zhou, M Li, K Zhou, J Brown, T Tsao, X Cen… - Cancers, 2022 - mdpi.com
Simple Summary Induced pluripotent stem cells (iPSCs) that can be genetically engineered
and differentiated into different types of immune cells, providing an unlimited resource for …

Induced pluripotent stem cells–derived hematopoietic progenitors for cellular immunotherapies

I Slukvin, SS D'Souza, A Kumar - iPSC Derived Progenitors, 2022 - Elsevier
Cellular therapies combined with genetic engineering technologies have emerged as
increasingly powerful tools for immunotherapies of cancers and viral infections including HIV …

[HTML][HTML] iPSC-derived natural killer cells for cancer immunotherapy

P Karagiannis, SI Kim - Molecules and cells, 2021 - Elsevier
The discovery of human pluripotent stem cells (PSCs) at the turn of the century opened the
door to a new generation of regenerative medicine research. Among PSCs, the donors …